mechanism 2,068 words KG: astrocyte
Contents

Astrocyte Dysfunction in Parkinson's Disease

Mechanism Info
Nameastrocyte
Key Genes/ProteinsABCA1, AGER, ALDH1L1, APOE, AQP4, BDNF
Related DiseasesAlzheimer's disease
Linked Hypotheses25 hypotheses

No AI portrait yet

Knowledge Graph

Related Hypotheses (120)

Phase-Separated Organelle Targeting
Score: 0.73
LRP1-Dependent Tau Uptake Disruption
Score: 0.60
SASP-Mediated Complement Cascade Amplification
Score: 0.98
TREM2-mediated microglial tau clearance enhancement
Score: 0.62
Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.73
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.82
Vagal Afferent Microbial Signal Modulation
Score: 0.62
Aquaporin-4 Polarization Rescue
Score: 0.73
SASP-Driven Aquaporin-4 Dysregulation
Score: 0.78
Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.54
Circadian-Synchronized LRP1 Pathway Activation
Score: 0.71
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.69
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.72
AMPK hypersensitivity in astrocytes creates enhanced mitocho
Score: 0.82
Adenosine-Astrocyte Metabolic Reset
Score: 0.73
Astrocyte-Mediated Neuronal Epigenetic Rescue
Score: 0.73
Circadian Rhythm Entrainment of Reactive Astrocytes
Score: 0.72
Astroglial Gap Junction Coordination via Connexin-43 Phospho
Score: 0.72
Mechanosensitive Ion Channel Reprogramming
Score: 0.70
Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th
Score: 0.69
pg 1/6Next →

Related Analyses (30)

Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · completed
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · completed
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · completed
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived

Related Experiments (30)

Cytochrome Therapeutics
clinical · proposed · Score: 0.40
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.45
Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson
clinical · proposed · Score: 0.40
GLP-1 Agonist Neuroprotection Mechanism in PD
clinical · proposed · Score: 0.40
Mechanism: Selective Vulnerability of Dopaminergic Neurons i
validation · proposed · Score: 0.40

See Also (11)

ABCA1 - ATP-Binding Cassette Transporter A1
gene · KG edge: expressed_in
ABCG1 Gene
gene · KG edge: expressed_in
ABCG4 Gene — ATP-Binding Cassette Subfamily G Member 4
gene · KG edge: expressed_in
ADAM10 — A Disintegrin And Metalloproteinase Domain 10
gene · KG edge: activates
ADNP Gene
gene · KG edge: expressed_in

Knowledge Graph (12 edges)

MAP1LC3B expressed_in astrocyte
CB2R expressed_in astrocyte
APOE regulates astrocyte
astrocyte associated_with Multiple sclerosis
NRF2 expressed_in astrocyte
BMAL1 expressed_in astrocyte
NOX4 expressed_in astrocyte
STAT3 regulates astrocyte
reactive_astrocyte associated_with astrocyte
C3 expressed_in astrocyte

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)